Mass General

Feb 1, 2021

Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker

Dec 29, 2020

In Fight Against Coronavirus, Developers Turn to Emerging, As Well As Established, Technologies

Aug 27, 2020

Natera, MGH to Collaborate in Early-Stage Breast Cancer Clinical Trial of Targeted Therapy

Aug 10, 2020

International Group Developing Point-of-Care Flow Cytometer for One-Day Diagnosis of Breast Cancer

Jul 1, 2020

ProterixBio Licenses Coronavirus Serology Test From Mass General

Jun 30, 2020

Fluxergy, Mass General Brigham Partner to Evaluate Rapid COVID-19 Molecular Testing System

May 11, 2020

Day Zero Diagnostics Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform

Apr 6, 2020

Mass General, CHOP, Northwestern Med Get FDA EUAs for SARS-CoV-2 Tests

Sep 24, 2019

CareDx, NanoString Collaborate to Develop Organ Transplant Rejection Test

Sep 16, 2019

Aethlon Medical Lands $1.9M SBIR Grant for Exosome Isolation Device

Feb 4, 2019

Clinical Utility of Polygenic Risk Scores Questioned in Commentary
Premium

Jan 24, 2019

Memorial Sloan Kettering Using Cerebral Spinal Fluid Liquid Biopsy, Sequencing to Track Glioma Evolution
Premium

Oct 31, 2018

Diagnostics Firm 1Drop Raises $4.25M

Oct 19, 2018

In Cell-based MDx, Microfluidics Needs Better Module Integration, Experts Say
Premium

Aug 27, 2018

With Rehm as Chief Genomics Officer, MGH Starts Studying Utility of WGS, Plans Genomic Risk Clinic
Premium

Aug 7, 2018

Researchers Integrate Genotyping Assay, Drug Delivery Tech for Precision Glioma Treatment
Premium

Jul 24, 2018

Researchers Developing Low-Cost POC For Molecular Diagnosis of Aggressive Lymphoma
Premium

May 22, 2018

Chembio, Mass General to Develop POC Tests for Fever Symptoms

Mar 23, 2018

In Brief This Week: Bruker, T2 Biosystems, Philips, and More

Mar 22, 2018

Mass General Developing Test for Very Early Detection of Sepsis